Dun & Bradstreet (DNB) Q2 Earnings Beat, Revenues Miss
The Dun & Bradstreet Corporation DNB reported mixed second-quarter 2017 results wherein adjusted earnings of $1.40 per share easily beat the Zacks Consensus Estimate of $1.16 but revenues of $405.7 million fell short of the consensus mark of $411.1 million.
On a year-over-year basis, the metrics registered growth of 2.2% and 1.7%, respectively.
Quarter Details
On an adjusted basis and after including forex effect, total revenue came in at $408.4 million, up 2.3% year over year. Adjusted deferred revenue was up 3% after including forex effect.
Organic revenues came in at $392.5 million, almost flat year over year.
Region-wise, adjusted revenues from the company’s Americas segment were up 2% year over year to $336.8 million while that from Non-Americas increased 3% to $71.6 million.
Segment-wise, on an adjusted basis and after including forex effect, Risk Management Solutions revenues from Americas was down 1% year over year to $183.3 million. Sales and Marketing Solutions revenues from the region grew 6% from the year-ago quarter to $153.5 million.
In Non-Americas, adjusted Risk Management Solutions revenues declined 2% year over year to $57.3 million. Sales and Marketing Solutions Non-Americas grew 23% from the year-ago quarter to $14.3 million.
Margins
On an adjusted basis, total operating costs were down 2% to $318.2 million. Adjusted total operating income was $90.2 million, up 3.8% year over year.
Dun & Bradstreet Corporation (The) Price, Consensus and EPS Surprise
Dun & Bradstreet Corporation (The) Price, Consensus and EPS Surprise | Dun & Bradstreet Corporation (The) Quote
Balance Sheet & Cash Flow
Dun & Bradstreet ended the quarter with $400.2 million in cash and cash equivalents and long-term debt of $1.673 billion. The company’s net debt position as of Jun 30, 2017 was $1.3 billion.
Cash flow from operating activities was $176.5 million year-to-date while free cash flow was $143.2 million, down 3.3% year over year.
Outlook
For 2017, management expects adjusted earnings per share to be down in the range of 4–7%. Adjusted revenues are expected to increase in the band of 3–5% (before forex effect).
Organic revenues are likely to increase in the band of 1–3% (before forex effect). Adjusted operating income is projected to be in the range of 0–2%.
Free cash flow will be in a bracket of $215–$245 million (excluding any regulatory fines impact from China operations).
Our Take
Dun & Bradstreet is expected to benefit from its high-margin business model and strong product portfolio. Its partnerships with big players have also aided it bring more customers into the fold. Additionally, the company is also well-positioned to gain from its strategic acquisitions and alliances. The company’s focus on expanding analytics capabilities is another positive.
Though Dun & Bradstreet’s Americas business remains strong, the international business continues to be a drag on financials. A weak DNBi business and a high debt are the other areas of concerns. Moreover, intensifying competition remains a major concern.
Zacks Rank & Share Price Movement
Presently, Dun & Bradstreet carries a Zacks Rank #3 (Hold).
Shares of Dun & Bradstreet have underperformed the industry in the last year. The company’s shares have decreased 21.2% against the industry’s gain of 3.6%.
Stocks to Consider
Better-ranked stocks in the broader tech space are Cutera, Inc. CUTR, Identiv, Inc. INVE and United States Cellular Corp. USM. All these three stocks sport a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank Stocks here.
In the trailing four quarters, Cutera, Identiv and United States Cellular delivered average positive earnings surprises of 231.25%, 51.41% and 37.84%, respectively.
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.
Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dun & Bradstreet Corporation (The) (DNB) : Free Stock Analysis Report
Identiv, Inc. (INVE) : Free Stock Analysis Report
Cutera, Inc. (CUTR) : Free Stock Analysis Report
United States Cellular Corporation (USM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research